High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry.
about
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT)Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometryA systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesProteomics and mass spectrometry for cancer biomarker discoveryApplications of diagonal chromatography for proteome-wide characterization of protein modifications and activity-based analyses.Enhanced peptide quantification using spectral count clustering and cluster abundance.Intelligent data acquisition blends targeted and discovery methods.A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography-mass spectrometry.Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry.Plant proteomics: concepts, applications, and novel strategies for data interpretation.Quantitation of protein phosphorylation in pregnant rat uteri using stable isotope dimethyl labeling coupled with IMAC.Human body fluid proteome analysis.Analysis of glycoproteins in human serum by means of glycospecific magnetic bead separation and LC-MALDI-TOF/TOF analysis with automated glycopeptide detection.Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry.Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry.High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasmaDifferential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics PlatformA non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS.Simultaneous characterization of glyco- and phosphoproteomes of mouse brain membrane proteome with electrostatic repulsion hydrophilic interaction chromatographySolid phase extraction of N-linked glycopeptides using hydrazide tipGlycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Setup for human sera MALDI profiling: the case of rhEPO treatment.Differential analysis of N-glycoproteome between hepatocellular carcinoma and normal human liver tissues by combination of multiple protease digestion and solid phase based labeling.The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics.Solid-phase extraction of N-linked glycopeptides.Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors.Identification of glycoproteins from mouse skin tumors and plasmaSialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay.Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues.Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance.Pairwise protein expression classifier for candidate biomarker discovery for early detection of human disease prognosis.Mass spectrometry based glycoproteomics--from a proteomics perspectiveIdentification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens.Boronic acid-functionalized detonation nanodiamond for specific enrichment of glycopeptides in glycoproteome analysis.Protein analysis by shotgun/bottom-up proteomicsLiquid Chromatography Mass Spectrometry-Based Proteomics: Biological and Technological Aspects.Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer.
P2860
Q24308771-F93CF950-9D03-4523-9036-FFD64A6C017AQ24684774-EE062FD6-C071-409E-BBFB-A3FB2C7DB684Q28732696-45917687-8F46-434B-A77A-F5FE70DD55A5Q28766969-D002A2C0-32D9-4A05-A56E-E9FA88EC5225Q30365942-15C095CE-83B6-4548-800B-3BF7C9F3DC3DQ30429321-95AD5E49-6E44-4FA5-89A4-ABE1C6172CECQ30773676-7E7B32A8-035A-4293-92C4-ECB3A61558AEQ30996936-5ED28C3D-936D-45F5-80AE-5B8A4863F21AQ31034801-F34AA887-F5F4-4D7A-A08C-141ED3AB2C7BQ31162278-1647E814-EE58-4527-8F60-07A6F980E2E6Q33233608-F019D410-6C75-4FA8-AC33-01E1ADCC0D9CQ33262623-4A1FE7C1-CE5C-4701-9429-4FA0E1691115Q33301622-E5BB9CB1-9EF6-48B4-BA38-18F263B24170Q33367998-BD9227D8-7222-4DDC-A5ED-CC208DC4A83AQ33516156-6129076C-3189-4290-A396-2DC3268F063FQ33579375-D959BEB9-F3D0-41FC-8454-4DB1FA00C6BEQ33589518-6ACD6909-F4E6-4CE1-8711-7184FA2C2260Q33649446-205B2297-60C3-4BA9-B106-BD9709469266Q33778879-BF626CED-F828-4D83-A8FF-1DF5AF8A8A94Q33812905-5B898E07-02AC-4604-AD81-553B2C876323Q33849938-92037656-9662-412C-83B0-C67C07FE2C1AQ33850638-9B0D0AA6-E6BA-4B4F-A75C-9458F5DD69BAQ33891197-E7117280-1A56-4023-B2CF-293F2A87EA24Q33943422-11176C6B-34D5-4A07-B9E2-9ED8AC3ED3B6Q33958684-2EF319FC-61A2-44C0-AF29-541C20D75214Q34073701-1C8614C8-A706-4DD0-AA5E-C63627EDF0ABQ34207316-4BAAF12A-B147-47B7-87C3-04663DEF079BQ34271181-F072D3CE-46D3-4E21-A632-A1FDECC50119Q34284388-1E61D3DB-78E7-4E47-9BA0-16E3CEEA6A35Q34289533-C54A5716-6CB7-47BD-A650-7526A14FE0CDQ34320706-C21E9A53-DAF2-421C-99F7-20C4508DE5CEQ34336108-D7E5E658-ED09-462C-8F63-1420075DFB9CQ34339902-ED699549-27F5-4B1F-A11E-900586178D70Q34369852-462CCF26-6E82-43C0-A6B4-35A9652445FDQ34454989-B136B2C5-0D58-4DAC-A411-68C1E079D3BEQ34533360-5C21FFB2-5E53-42D4-84F0-DDB95788193FQ34574366-6D4537BE-724F-4267-9442-EB8B01A79F30Q34600986-021837C9-7036-43DE-9538-A40CB577AC8BQ34983181-D986DA97-FE51-4B9F-8E06-235AD32FBDCFQ35026909-6B07DA1E-840C-430A-9223-70C67DAA33CD
P2860
High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
High throughput quantitative a ...... omatography mass spectrometry.
@ast
High throughput quantitative a ...... omatography mass spectrometry.
@en
type
label
High throughput quantitative a ...... omatography mass spectrometry.
@ast
High throughput quantitative a ...... omatography mass spectrometry.
@en
prefLabel
High throughput quantitative a ...... omatography mass spectrometry.
@ast
High throughput quantitative a ...... omatography mass spectrometry.
@en
P2093
P2860
P1476
High throughput quantitative a ...... omatography mass spectrometry.
@en
P2093
Christophe D Masselon
Christopher J Kemp
David G Camp
Eugene C Yi
Karen S Kelly-Spratt
Parag Mallick
Xiao-jun Li
P2860
P304
P356
10.1074/MCP.M400090-MCP200
P577
2004-12-17T00:00:00Z